[{"orgOrder":0,"company":"Coeruleus Ltd.","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"UNITED KINGDOM","productType":"Miscellaneous","year":"2010","type":"Inapplicable","leadProduct":"Flumazenil","moa":"GABA-A receptor; anion channel","graph1":"Undisclosed","graph2":"Phase I\/ Phase II","graph3":"Coeruleus Ltd.","amount2":0,"highestDevelopmentShortName":"Ph I\/II","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Spray","sponsorNew":"Coeruleus Ltd. \/ Undisclosed","highestDevelopmentStatusID":"7","companyTruncated":"Coeruleus Ltd. \/ Undisclosed"},{"orgOrder":0,"company":"Coeruleus Ltd.","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Sleep","country":"UNITED KINGDOM","productType":"Miscellaneous","year":"2012","type":"Inapplicable","leadProduct":"Flumazenil","moa":"GABA-A receptor; anion channel","graph1":"Sleep","graph2":"Phase I","graph3":"Coeruleus Ltd.","amount2":0,"highestDevelopmentShortName":"Ph I","therapeuticAreaShortName":"Sleep","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Coeruleus Ltd. \/ Undisclosed","highestDevelopmentStatusID":"6","companyTruncated":"Coeruleus Ltd. \/ Undisclosed"},{"orgOrder":0,"company":"Prisma Health-Midlands","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Neurology","country":"U.S.A","productType":"Miscellaneous","year":"2018","type":"Inapplicable","leadProduct":"Flumazenil","moa":"GABA-A receptor; anion channel","graph1":"Neurology","graph2":"Phase I","graph3":"Prisma Health-Midlands","amount2":0,"highestDevelopmentShortName":"Ph I","therapeuticAreaShortName":"Neurology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Prisma Health-Midlands \/ Undisclosed","highestDevelopmentStatusID":"6","companyTruncated":"Prisma Health-Midlands \/ Undisclosed"}]

Find Clinical Drug Pipeline Developments & Deals for DSSTox_CID_3064

Menu
Xls
Filters Filter
×
FILTER:
filter
Company Name
    filter

    Year

      filter

      DEALS // DEV.

        filter

        Country

          filter
          Sponsor
            filter

            Therapeutic Area

              filter

              Study Phase

                filter

                Deal Type

                  filter

                  Product Type

                    filter

                    Dosage Form

                      filter

                      Lead Product

                        filter

                        Target

                          Loading...

                          Therapeutic Area by Lead Product

                          Study Phase by Lead Product

                          Company by Lead Product

                          Top Deals by Deal Size (USD bn)

                          01

                          Prisma Health-Midlands

                          Country arrow
                          AllPack Indonesia
                          Not Confirmed

                          Prisma Health-Midlands

                          Country arrow
                          AllPack Indonesia
                          Not Confirmed

                          Details : Flumazenil is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Brain Death.

                          Product Name : Undisclosed

                          Product Type : Miscellaneous

                          Upfront Cash : Inapplicable

                          November 16, 2018

                          Lead Product(s) : Flumazenil

                          Therapeutic Area : Neurology

                          Highest Development Status : Phase I

                          Sponsor : Undisclosed

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          02

                          Coeruleus Ltd.

                          Country arrow
                          AllPack Indonesia
                          Not Confirmed

                          Coeruleus Ltd.

                          Country arrow
                          AllPack Indonesia
                          Not Confirmed

                          Details : Flumazenil is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Sleep Initiation and Maintenance Disorders.

                          Product Name : Undisclosed

                          Product Type : Miscellaneous

                          Upfront Cash : Inapplicable

                          August 02, 2012

                          Lead Product(s) : Flumazenil

                          Therapeutic Area : Sleep

                          Highest Development Status : Phase I

                          Sponsor : Undisclosed

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          03

                          Coeruleus Ltd.

                          Country arrow
                          AllPack Indonesia
                          Not Confirmed

                          Coeruleus Ltd.

                          Country arrow
                          AllPack Indonesia
                          Not Confirmed

                          Details : Flumazenil is a Other Small Molecule drug candidate, which is currently being evaluated in phase I/ phase II clinical studies for the treatment of undefined medical condition.

                          Product Name : Undisclosed

                          Product Type : Miscellaneous

                          Upfront Cash : Inapplicable

                          February 19, 2010

                          Lead Product(s) : Flumazenil

                          Therapeutic Area : Undisclosed

                          Highest Development Status : Phase I/ Phase II

                          Sponsor : Undisclosed

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank